Cardio Diagnostics
CDIO
14 hedge funds and large institutions have $152K invested in Cardio Diagnostics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
40% more funds holding
Funds holding: 10 → 14 (+4)
0% more ownership
Funds ownership: 0.12% → 0.13% (+0%)
66% less capital invested
Capital invested by funds: $445K → $152K (-$293K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$25.8K |
| 2 |
Renaissance Technologies
New York
|
+$14.3K |
| 3 |
HF
HRT Financial
New York
|
+$9.04K |
| 4 |
PCM
Prelude Capital Management
New York
|
+$8.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.34K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
1
Prelude Capital Management
New York
| $41.1K | +$8.8K | +366 | +10% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $25.7K | – | – | – |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $21.8K | – | – | – |
|
|
LA
4
Linden Advisors
New York
| $15.5K | – | – | – |
|
5
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $13.8K | – | – | – |
|
|
TSS
6
Two Sigma Securities
New York
| $11K | +$25.8K | +1,075 | New |
|
7
State Street
Boston,
Massachusetts
| $6.83K | – | – | – |
|
|
8
Renaissance Technologies
New York
| $6K | +$14.3K | +593 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $3.3K | +$3.34K | +139 | +75% |
|
|
HF
10
HRT Financial
New York
| $3K | +$9.04K | +376 | New |
|
|
CSC
11
Caldwell Sutter Capital
Sausalito,
California
| $2.75K | – | – | – |
|
|
WAM
12
Wolverine Asset Management
Chicago,
Illinois
| $1.63K | – | – | – |
|
13
UBS Group
Zurich,
Switzerland
| $21 | +$48 | +2 | New |
|
14
Wells Fargo
San Francisco,
California
| $16 | +$24 | +1 | +100% |
|
15
JP Morgan Chase
New York
| $2 | – | – | – |
|
CDIO Hedge Fund Activity: Q3 2023 in Review
14 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q3 2023, worth a combined $152K — down 66% from $445K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CDIO positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $25.8K.
- 14 institutional investors held Cardio Diagnostics (CDIO) as of Q3 2023, up from 10 in Q2 2023.
- Funds reported $152K of Cardio Diagnostics stock for Q3 2023, down 66% quarter-over-quarter.
- 4 funds opened new Cardio Diagnostics positions in Q3 2023 and 0 closed out, a net change of +4 holders.
- The largest Cardio Diagnostics buyer in Q3 2023 was Two Sigma Securities, an estimated $25.8K added.
Based on aggregated 13F filings for Q3 2023.